NIM
MLYS icon

NEOS Investment Management’s Mineralys Therapeutics MLYS Stock Holding History

NEOS Investment Management’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,463
Closed -$235K – 624
2025
Q4 		$235K Buy
+6,463
New +$259K ﹤0.01% 646
2025
Q1 		– Sell
-89,529
Closed -$1.1M – 612
2024
Q4 		$1.1M Sell
89,529
-33,969
-28% -$444K 0.03% 394
2024
Q3 		$1.5M Buy
123,498
+50,685
+70% +$614K 0.05% 310
2024
Q2 		$852K Buy
72,813
+2,073
+3% +$26.1K 0.04% 357
2024
Q1 		$913K Buy
70,740
+46,767
+195% +$578K 0.06% 283
2023
Q4 		$206K Buy
+23,973
New +$188K 0.02% 493

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

NEOS Investment Management's MLYS Position: Q1 2026 in Review

NEOS Investment Management sold out of Mineralys Therapeutics (MLYS) in Q1 2026, closing a stake of 6,463 shares — an estimated $235K sold.

NEOS Investment Management first reported a position in MLYS in Q4 2023 and held it in 6 quarters. The position peaked at $1.5M in Q3 2024. 214 funds tracked by Wall St. Rank hold MLYS as of Q1 2026.

  • NEOS Investment Management reported no remaining Mineralys Therapeutics position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 6,463 Mineralys Therapeutics shares in Q1 2026, an estimated $235K.
  • NEOS Investment Management first reported a position in Mineralys Therapeutics in Q4 2023 and held it in 6 quarters.
  • NEOS Investment Management's Mineralys Therapeutics position peaked at $1.5M in Q3 2024.
  • 214 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.